Understanding Your ROI

John Elliott from Carevive delves into the pressing question of ROI in the evolving landscape of value-based care reimbursement models. As the oncology care model (OCM) transitions into the enhancing oncology model, stakeholders are evaluating the technology, processes, and resources that will support their future endeavors.

Carevive proves to be a twofold solution, seamlessly aligning with the current fee-for-service model for chronic care management. By providing tools and solutions to manage symptoms, Carevive aids in avoiding hospitalizations and enhancing patient outcomes, leading to additional revenue and reimbursements for partners.

Moreover, Carevive is firmly positioned to align with the future enhanced oncology model, as it focuses on driving transformation, quality metrics, and health equity advancement. The integration of electronic patient-reported outcomes (ePROs) exemplifies Carevive’s commitment to symptom remote management, a vital component of the future model.

Recent Episodes

Hospitals across the country are feeling the strain—too many open roles, not enough trained professionals, and a growing gap between what students learn and what the job actually demands on day one. Training is getting more expensive, timelines are stretching, and healthcare leaders are being forced to rethink how new clinicians enter the field….

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…